• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
SCOTUS Won’t Weigh in on How Whistleblowers Make Valid FCA Claims

SCOTUS Won’t Weigh in on How Whistleblowers Make Valid FCA Claims

by Glenn S. Demby | Nov 17, 2022 | Enforcement-nir, Essential, National Lab Reporter

The court recently denied the petition to hear a case that would have helped offer clarity on what evidence whistleblowers need to file qui tam lawsuits under the FCA.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Compliance Tool: Whistleblower Non-Retaliation Policy

Compliance Tool: Whistleblower Non-Retaliation Policy

by Glenn S. Demby | Oct 28, 2022 | Compliance Guidance-lca, Essential, Lab Compliance Advisor

How to create a written policy banning retaliation for whistleblowing and for investigating retaliation complaints.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
When Qui Tam Retaliation Lawsuits Get Tricky

When Qui Tam Retaliation Lawsuits Get Tricky

by Glenn S. Demby | Oct 28, 2022 | Essential, False Claims-lca, Lab Compliance Advisor

What happens when a compliance officer is the whistleblower in a qui tam retaliation lawsuit?

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
False Billing of Lab Tests and Two Dismissed Lawsuits

False Billing of Lab Tests and Two Dismissed Lawsuits

by Glenn S. Demby | Sep 28, 2022 | Essential, Lab Compliance Advisor, Labs in Court-lca

This month’s key lab cases involve false billing of urine drug and PGx tests and two lawsuits that were tossed.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Feds Lower the Boom on Home Sleep Test False Billing and Kickbacks

Feds Lower the Boom on Home Sleep Test False Billing and Kickbacks

by Glenn S. Demby | Sep 28, 2022 | Enforcement-lca, Essential, Lab Compliance Advisor

A recent $3.5 million settlement illustrates the kinds of pitfalls that can result in liability for hospital and freestanding sleep labs.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries
Next Entries »

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com